Auro Laboratories Ltd vs Blue Jet Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Auro Laboratories Ltd is ₹ 261.5 as of 06 May 15:30 . The P/E Ratio of Auro Laboratories Ltd is 0 as of March 2021 .The P/E Ratio of Blue Jet Healthcare Ltd is 0 as of March 2021 . The Market Cap of Auro Laboratories Ltd is ₹ 0 crore as of March 2021 .The Market Cap of Blue Jet Healthcare Ltd is ₹ 0 crore as of March 2021 . The revenue of Auro Laboratories Ltd for the Sep '25 is ₹ 9.81 crore as compare to the Jun '25 revenue of ₹ 3.19 crore. This represent the growth of 207.52% The revenue of Blue Jet Healthcare Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Auro Laboratories Ltd for the Sep '25 is ₹ 3.33 crore as compare to the Jun '25 ebitda of ₹ 0.45 crore. This represent the growth of 640% The ebitda of Blue Jet Healthcare Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Auro Laboratories Ltd changed from ₹ 0.75 crore to ₹ 0.72 crore over 4 quarters. This represents a CAGR of -4.00% The net profit of Blue Jet Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of 0.0% The Dividend Payout of Auro Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Blue Jet Healthcare Ltd changed from 10.59 % on March 2024 to 6.82 % on March 2025 . This represents a CAGR of -19.75% over 2 years .

About Auro Laboratories Ltd

Auro Laboratories Limited, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API).
Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes.
The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra.
The facility has all the required certifications from Indian authorities and European registration organization Since inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards.
Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA. The Company's primary focus was on Anti-Diabetic Drugs, which estimated to be one of the fastest growing therapeutic segments.

About Blue Jet Healthcare Ltd

Blue Jet Healthcare Limited was originally incorporated as Jet Chemicals Private Limited,' at Mumbai, dated December 7, 1968.
The Company name was changed to Blue Jet Healthcare Private Limited', and a fresh Certificate of Incorporation dated December 30, 2020, was issued by the Registrar of Companies, Mumbai.
Subsequently, the status got converted into a Limited Company and its name was changed to Blue Jet Healthcare Limited' on May 18, 2022. The Company is a global, science-led, pharmaceutical company evolved as strategic partner for Collaboration, Development & Manufacturing of Advance Pharmaceutical Intermediates and API. It operate into 3 product categories, contrast media intermediates, high- intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs).

FAQs for the comparison of Auro Laboratories Ltd and Blue Jet Healthcare Ltd

Which company has a larger market capitalization, Auro Laboratories Ltd or Blue Jet Healthcare Ltd?

Market cap of Auro Laboratories Ltd is 162 Cr while Market cap of Blue Jet Healthcare Ltd is 8,472 Cr

What are the key factors driving the stock performance of Auro Laboratories Ltd and Blue Jet Healthcare Ltd?

The stock performance of Auro Laboratories Ltd and Blue Jet Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Auro Laboratories Ltd and Blue Jet Healthcare Ltd?

As of May 6, 2026, the Auro Laboratories Ltd stock price is INR ₹261.5. On the other hand, Blue Jet Healthcare Ltd stock price is INR ₹488.4.

How do dividend payouts of Auro Laboratories Ltd and Blue Jet Healthcare Ltd compare?

To compare the dividend payouts of Auro Laboratories Ltd and Blue Jet Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.